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Abstract
The endometrial lining of the human uterus contains a population of phenotypically distinct
(CD56bright, CD16dim), tissue-specific, natural killer (uNK) cells that play a key role in
establishment of a successful pregnancy. An increase in the number of endometrial uNK cells
occurs when the conceptus implants and there is a further rise during the early stages of
placentation. Here we describe studies that have identified chorionic gonadotrophin (hCG), a
glycoprotein synthesised by the pre-implantation conceptus, as a novel regulator of uNK cell
proliferation. The impact of hCG on uNK cells was mediated via the mannose receptor (MR,
CD206) rather than by the classical hCG/LH receptor that was not expressed. MR and hCG were
co-localised on the surface of uNK cells and proliferation did not occur if cells were incubated
with deglycosylated-hCG or intact hCG in the presence of excess D-Mannose. These novel
observations provide new insight into the endocrine-immune dialogue that exists between the
conceptus and immune cells within the receptive endometrium and have implications for the role
of uNK cell-trophoblast interactions and pregnancy outcome.
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Introduction
The endometrium contains a population of CD56brightCD16dim endometrial natural killer
cells (uNKs) that are distinct from circulating peripheral CD56dimCD16bright NK cells,
reviewed in (1). The number of CD56bright cells increases at the onset of decidualisation
during the secretory phase of the menstrual cycle (2, 3) with a further increase as a result of
successful implantation. As a result uNK cells become the predominant lymphocyte subtype
in the decidua during the first trimester of pregnancy (4).
Uterine NK cells play a key role in establishment, maintenance and regulation of early
pregnancy (3) and a number of studies have suggested that they are aberrantly regulated in
unexplained recurrent pregnancy loss (RPL) and in fetal growth restriction (5). For example,
three studies have reported that the endometrium of women with RPL had increased
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numbers and/or activity of peripheral type NK cells (reviewed in (5)). In addition, although
there may not be a difference in the total number of uNK cells in women with RPL the
phenotype of the uNK cells may be altered and there is evidence that endometrium from
women with RPL contain less CD56bright CD16dim uNK cells as compared to endometrium
of fertile control patients (6). Reduced NK cell populations are also reported in pregnancies
complicated by fetal growth restriction (FGR) with or without accompanying pre-eclampsia
(7).
At present the lineage, origin and mechanism underlying the postovulatory and early
pregnancy expansion of uNK cells remains to be established. Although variation in uNK cell
number across the menstrual cycle suggests ovarian steroid regulation (5, 8) neither
progesterone receptor (PR) nor oestrogen receptor alpha (ERα) have been detected in
human uNK cells (9, 10). In addition, the rise in cell numbers that occurs at the time of
implantation remains unexplained and although recruitment of migratory precursor cells
may occur (1) the potential that local regulators may drive expansion within the tissue has
prompted us to investigate what other factors might be involved in stimulating uNK cell
proliferation.
Human chorionic gonadotrophin (hCG) is one of the earliest proteins secreted by the fetal
trophoblast and is thus a candidate for regulation of paracrine embryo-endometrial dialogue.
hCG is a heterodimeric glycoprotein that has an identical alpha subunit to that of luteinizing
hormone (LH) originating from the pituitary gland, and a unique beta subunit. Both proteins
can bind to the LH receptor, a transmembrane G-protein coupled receptor that is expressed
on ovarian cells (11) and macrophages from term placenta and late secretory phase non-
pregnant endometrium (12, 13). Mature hCG and LH are both modified by N-linked
carbohydrate side chains that are important for the stability and assembly of the proteins
(14).
We hypothesised that hCG secreted by the conceptus may directly mediate expansion of
uNK cells during early stages of placentation. We therefore examined whether uNK cells
express either the LH/hCG receptor or the mannose receptor (MR, CD206), a cell surface
lectin that binds glycoproteins with N-linked carbohydrate side chains (15).
We report novel experimental data demonstrating that hCG can induce a signficant increase
in uNK cell number. We propose that these findings necessitate a paradigm shift of the
mechanisms that regulate this critical cell population during establishment of a fully
functional placenta.
Materials and Methods
Human uterine tissue collection
Endometrial tissue specimens were obtained from non-pregnant women of reproductive age
undergoing surgery for non-malignant gynaecological conditions (n = 9). Local ethical
committee approval was granted and written, informed, patient consent was obtained prior
to tissue collection. Histology, as assessed according to (16), was consistent with the
patient’s reported last menstrual period and circulating steroid levels at time of tissue
collection (17). Decidual tissue was obtained from women (n = 12; gestational age 7 -9
weeks) who had undergone first trimester surgical termination of pregnancy. All these
women had an ultrasound scan to confirm a viable intrauterine pregnancy and gestational
age. Decidua parietalis tissue was selected by macroscopic inspection.
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Preparation of uNK cell population
NK cells were isolated from endometrial or decidual samples as previously described (18)
and CD56bright uNKs were further purified by positive selection using CD56 antibody-
coated magnetic Microbeads and the MACS® system (Miltenyi Biotec Ltd, Surrey, UK).
Purified cells were seeded in 6-well plates at a concentration of 2.5 × 106 cells/ml and
cultured in RPMI 1640 medium (Sigma) supplemented with 10 % FCS (Mycoplex),
penicillin (50 μg/ml; Sigma), streptomycin (50 μg/ml; Sigma) and gentamycin (5 μg/ml;
Sigma). Cells were incubated with hCG (10 ng/ml-10000 ng/ml) (Organon) in the presence
or absence of D-Mannose (1 mg/ml) (Sigma) for 24 h at 37°C in 5 % (v/v) CO2 or with hCG
that had been deglycosylated using PNGase F (Sigma) according to standard methods.
Cell proliferation assay
Cellular proliferation was measured by a non-radioactive cell proliferation assay system
(MTT assay; Roche, Mannheim, Germany).
Semi Quantitative RT-PCR
RNA was isolated using the Qiagen RNeasy Mini Kit (Qiagen) and cDNA prepared using
random hexamer primers (PE Biosystems, Warrington, UK). Target cDNAs, MR (Forward:
CTACCCCTGCTCCTGGTTTTT, Reverse: TGAAACACTCATAATCTGAGATTC, 203
bp) and LH/hCG receptor (Forward: ATGAAGCAGCGGTTCTCG, Reverse:
TTGACAGGGAGGTAGGCAAG, 203 bp), were amplifed using BioMix (BioMix Red,
Bioline Ltd, London, UK) and BIOTAQ DNA Polymerase (Bioline Ltd). Amplification of
GAPDH (Forward: CTGCACCACCAACTGCTTAGC, Reverse:
ATGCCAGTGAGCTTCCGTTC, 205 bp) was used as an internal control for integrity of the
RNA samples. 30 cycles of amplification were performed with an initial denaturing
temperature of 95°C for 5 min for 1 cycle followed by 30 cycles of: denaturation at 95°C for
30 sec, annealing for 30 sec and extension at 72°C for 1 min 30 sec. Final extension at 72°C
was carried out for 10 min. Amplified products were visualised on agarose gels. A sample of
RNA extracted from human corpus luteum was included as a positive control for LHR.
Immunocytochemistry
uNK cells were prepared for immunostaining by Shandon Cytospin® (Thermo Electron
Corporation, Cheshire, UK), briefly 1 × 105 cells were fixed in methanol for 10 min at room
temperature and incubated with mouse monoclonal anti-human CD56 (Zymed) overnight at
4°C and then with peroxidase goat anti-mouse antibody (Dako UK Ltd) for 30 min followed
by Tyramide Cy3 for 10 min at room temperature. Co-localisation of hCG and MR was
explored by incubating the cells at 4°C overnight with rabbit polyclonal anti-human hCG
(Abcam), then biotinylated goat anti-rabbit antibody (Dako UK Ltd) for 30 min followed by
streptavidin 546 (Molecular Probes) for 60 min each at room temperature. After washing
cells were incubated with mouse monoclonal anti-human MR (Abcam) followed by
biotinylated goat anti-mouse antibody (Dako UK Ltd) for 30 min and streptavidin 488
(Molecular Probes) for 60 min each at room temperature. Negative controls were incubated
with secondary antibodies alone and all nuclei were counterstained with DAPI. Fluorescent
images were obtained on a LSM 510 confocal microscope (Carl Zeiss).
Flow cytometry
FACS analysis of was carried out on cells stained with phycoerythrin-conjugated mouse
anti-human MR-specific (CD206) and fluorescein isothiocyanate-conjugated mouse anti-
human CD56-specific antibody (BD Pharmingen).
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Mass Spectrometry
Mass spectrometry was performed on an Applied Biosysetms Voyager DE-STR MALDI-
TOF instrument using a sinapinic acid matrix to analyse hCG protein.
Statistical Analysis
Prior to statistical analysis data were tested for, and shown to exhibit, Gaussian distribution
by applying the Shapiro-Wilk normality test to the data. Where appropriate, values were
presented as mean ± S.E.M. Comparison of the different parameters for the various
treatment groups was determined by repeated measures analysis of variance (ANOVA).
Significant differences were assigned using Kruskal-Wallis post hoc test. The criterion for
significance for all tests was set at p < 0.05. Specific software was used to assist in the data
analysis (GraphPad Prism v4.0b for Macintosh, GraphPad Software, San Diego, USA).
Results
Isolation and characterisation of uNK cells from non-pregnant late secretory phase human
endometrium and first trimester human decidua
FACS analysis demonstrated that the purity of the purified uNK cells from non-pregnant late
secretory phase human endometrium was ~95% (Fig. 1 D). Immunocytochemistry
confirmed that these isolated cells expressed CD56 on their surface (Fig. 1 E). Decidual NK
cells isolated using the same procedures were typically >90 % pure (Supplementary Fig S1).
Uterine NK cells express the mannose receptor (MR, CD206) but not the LH/hCG receptor
RNA was extracted from highly purified populations of NK cells obtained from both non-
pregnant endometrium and first trimester decidua and RTPCR was performed using primers
specific for LHR and MR. MR mRNA was detected in all samples of purified NK cells (Fig.
2A) but these samples did not contain measurable LHR mRNA even though this was readily
detected in an extract from human corpus luteum (Fig. 2 B). Expression of MR protein on
the surface of CD56 positive uNK cells was demonstrated using FACS (Fig. 2 C-H) and
immunofluorescence (Fig. 3) with a specific anti-CD206 antibody. Although MR is a cell
surface receptor it is internalised following binding to carbohydrates and thus the cells were
permeabilised prior to immunostaining; ~40% of the CD56 positive uNK cells (Fig 2F)
population were confirmed as positive for MR (CD206), using FACS (Fig 2 G, upper left
quadrant). In parallel analyses ~35 % of uNK cells stained positive for both CD206 and
CD56 (Fig 2H upper right quadrant). When immunostained cells were visualised using a
confocal microscope MR was clearly localised to the purified uNK cells (Fig. 3 middle
panel). Notably the antibody staining was not uniform but appeared clustered (Fig. 3 I, II, V)
and the intensity of the immunopositive staining varied between cells (Fig. 3 II, V, VIII, XI).
Binding of hCG to uNK cells is dependent upon the presence of N-linked carbohydrate
side chains containing terminal mannose residues
After intact hCG was added to incubation medium it could be detected on the surface of the
majority of purified uNK cells (Fig 3 VI) and notably co-localisation with antigenic sites
positive for MR was also demonstrated (Fig 3 IV, yellow staining) although there was not a
complete/uniform overlap in immunoreactivity. As we expected binding of hCG to be
dependent upon the presence of N-linked carbohydrate side chains containing terminal
mannose residues we also performed immunostaining with intact hCG in the presence of
excess D-mannose (Fig. 3 VII-IX) or with deglycosylated hCG (Fig. 3X-XII). In both cases,
although MR immunoexpression was still detectable (green Fig 3 VIII, XI), no hCG was
detected bound to the cell surface.
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Human chorionic gonadotrophin stimulates uterine NK cell proliferation (Figure 4)
To investigate whether there was a link between expression of the MR in uNK cells, hCG
binding and uNK cell number, we evaluated uNK cell proliferation in cells incubated with a
range of concentrations of hCG alone or in the presence of excess D-mannose (1 mg/ml) for
24h (Fig. 4A). A significant dose-dependent increase in proliferation of uNK cells was
observed at 1000 ng/ml hCG (Fig. 4A p<0.05) and 10000 ng/ml hCG (Fig 4A p<0.001).
However no proliferation was induced at any concentration of hCG in the presence of excess
D-mannose (1 mg/ml) (Fig 4A).
In order to test whether the protein backbone of hCG was able to alter uNK cell number the
protein was deglycosylated with PNGase (Fig. 4 B-D) and incubated with uNK cells at
identical concentrations to that used for the intact, glycosylated protein. Under these
conditions no uNK cell proliferation was detected (Fig. 4A).
We were also unable to demonstrate any increase in numbers of uNK cells when cells were
incubated with either LH (10000 ng/ml) or FSH (0.1 IU) for 24 h (data not shown).
Discussion
Natural killer cells represent the largest leukocyte population in the placenta of early
pregnancy and although the increase in the number of uNK cells coincides with implantation
and early stages of placentation the mechanism remains unknown. Chorionic gonadotrophin
(hCG) is one of the earliest proteins secreted by the fetal trophoblast. In the present study we
have described experimental results that have identified chorionic gonadotrophin (hCG), one
of the earliest proteins secreted by the pre-implantation conceptus, as a novel regulator of
uNK cell proliferation. The impact of hCG on uNK cells was shown to be mediated via the
mannose receptor (MR, CD206) rather than by the classical hCG/LH receptor that was not
expressed. MR and hCG were co-localised on the surface of uNK cells and proliferation did
not occur if cells were incubated with deglycosylated-hCG or intact hCG in the presence of
excess D-Mannose.
Our results suggest that cell surface lectins, that have the ability to recognise carbohydrate
moieties in glycosylated proteins, may play a role in hCG-mediated uNK cell proliferation.
The MR (CD206) contains eight tandemly arranged C-type lectin-like domains that mediate
binding to mannose, fucose, or N-acetylglucosamine in a Ca2+-dependent manner (19).
Binding of hCG to peripheral blood monocytes has previously been attributed to C-type
lectins although the expression of MR was not investigated (20). MR mRNA, but not LHR
mRNA, was detected in all samples of purified CD56brightNK cells and expression of MR
protein was demonstrated on the surface of purified uNK cells using both FACS and
immunofluorescence. Although the MR is a cell surface receptor it is internalised following
binding to carbohydrates and this was the reason for permeabilising the cells prior to
immunostaining. Variations in percentages between FACS and immunocytochemistry may
be attributable to either the primary antibody masking antigenic sites or preventing binding
of the other antibody to the cells, and may be influenced by shuttling of the MR. so that the
pattern of staining observed is a reflection of the rapid recycling of the MR between the cell
surface and intracellular compartments (15).
In order to establish whether hCG could bind directly to uNK cells CD56Bright NK cells
were isolated from late secretory (non-pregnant) endometrium using positive selection with
CD56 antibody-coated magnetic microbeads and magnetic assisted cell separation. We
reasoned that as these cells had not been exposed to proteins from the conceptus any
putative binding sites would not be blocked by endogenous protein(s). Mature hCG and LH
are modified by N-linked carbohydrate side chains that are important for the stability and
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assembly of the proteins (14). We further demonstrated that binding of hCG to uNK cells
was dependent upon the presence of N-linked carbohydrate side chains containing terminal
mannose residues.
A significant dose-dependent increase in proliferation of uNK cells was observed in
response to incubation with hCG whereas no proliferation was induced at any concentration
of hCG in the presence of excess D-mannose. Furthermore no uNK cell proliferation was
detected when the protein backbone of hCG was deglycosylated with PNGase and incubated
with uNK cells at identical concentrations to that used for the intact, glycosylated protein.
These observations indicated that not only is hCG-mediated binding to uNK cell
carbohydrate specific but cell proliferation was also carbohydrate dependent.
We were unable to induce uNK cell proliferation with the other closely related glycoprotein
hormones, LH and FSH. LH and FSH share a common α subunit with hCG, but their
carbohydrate side chains are not identical (21). Despite a high degree of homology between
the LH and CG beta subunits they are reported to differ in their effect on the N-linked
oligosaccharide processing of the alpha subunit (22). Furthermore, a previous study has
reported that a hyper-glycosylated form of hCG is formed early in pregnancy and is then
rapidly replaced by less glycosylated isoforms, suggesting that the hCG glycoforms also
change dynamically as pregnancy progresses (23).
These results are of particular interest when considered in parallel with the fluctuation in NK
cell number during pregnancy; the dNK population is maximal in the first trimester of
pregnancy but declines in the second trimester. These observations provide an explanation
for the results of our study showing uNK proliferation was only stimulated by glycosylated
hCG and not by LH and provide a mechanism by which the embryo signals its presence to
local maternal immune systems facilitating trophoblast implantation and successful
establishment of pregnancy. During the normal cycle a peak of LH occurs at the time of
ovulation however a significant increase in numbers of uNK cells occurs several days later
at the time of decidualisation and this is consistent with our results showing LHR was not
expressed on uNK cells.
The daily rate of increase in hCG is lower in failing pregnancies and circulating hCG
concentrations are predictive of viable or non-viable (miscarriage and ectopic gestation)
pregnancy outcome (24). The endometrium of women with RPL exhibits a greater
percentage of CD16Bright, CD56dim uNK cells and a smaller percentage of the CD16dim,
CD56Bright uNK cell population, as compared to endometrium of fertile control patients (25,
26). As CD16Bright cells demonstrate greater cytolytic activity than CD16dim NK cells an
increased number of CD16Bright cells in the decidua may be a factor in early miscarriage (5).
Reduced NK cell populations are also reported in pregnancies complicated by fetal growth
restriction (FGR) with or without accompanying pre-eclampsia (7). In this context reduced
NK cell numbers in the decidua basalis of women with fetal growth restriction supports a
crucial role for uterine NK cell-trophoblast interactions in adequate placental development
(7). Indeed, it is likely that uNK cells play an important role at the earliest stage of
pregnancy, both in the remodelling of the spiral arteries (27) and the decidualisation of the
endometrium. Adequate decidualisation and vascular remodelling are essential for the
establishment of a successful pregnancy.
CD56Bright NK cells are also considered to be distinct clinico-pathological entities in
malignant conditions and are typically referred to as NK cell lymphoma (28). Clinically,
most cases of NK cell lymphoma affect the nasal cavity or other parts of the upper
aerodigestive tract (28). Other sites such as the skin, gastrointestinal tract and testis, have
also been documented and are usually referred to as extra nasal NK cell lymphoma (28).
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hCG is an established tumor-associated antigen that is over-expressed in a variety of
common cancers (29) and serum hCG levels have proved to be a useful diagnostic tool both
for monitoring tumor burden and for evaluating the effectiveness of therapeutic intervention
(30). For example, elevated hCG has been demonstrated to be an independent predictor of
an unfavorable disease outcome and has been associated with a more aggressive disease
course in renal, colorectal, bladder, and pancreatic cancers (31, 32). It has been proposed
mechanistically that hCG may act at several different levels to facilitate cancer progression,
as a transforming growth factor, an immunosuppressive agent, an inducer of metastasis, and/
or as an angiogenic factor (29). To date, no data are available on hCG levels in patients with
NK cell lymphomas however our new findings suggest that therapies blocking hCG
production or action could provide a novel therapy for this type of cancer or others where
the MR is expressed.
In summary, we have shown for the first time that the MR is expressed on CD56brightNK
cells isolated from both non-pregnant endometrium and first trimester decidua. Furthermore
we report that uterine NK cells can bind hCG but do not express the classical LH/hCG
receptor. MR and hCG were co-localised to the surface of uNK cells and incubation with
intact glycosylated hCG induced nNK cell proliferation that was blocked if cells were
incubated with hCG in the presence of excess D-Mannose. We propose that the proliferation
of uNK cells in the early stages of pregnancy is regulated by hCG produced by the
trophoblast of the conceptus and that hCG-carbohydrate-side chain recognition by the MR is
fundamental in propagating non-canonical hCG signaling. Therefore, carbohydrate
recognition, a highly conserved process, may orchestrate the dynamic and complex milieu of
the uterine environment in which an immune-endocrine network involving hCG and uNK
cells exists, and could be the focus of future therapeutic interventions. These data have
implications for management of miscarriage and the development of conditions such as fetal
growth restriction that have a life-long impact on health and wellbeing.
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Figure 1. Isolation and characterisation of uNK cells from non-pregnant late secretory phase
human endometrium
FACS analysis showing of cells incubated with the isotype-matched negative control (A) or
CD56 antibody (B): y axis is forward scatter and x axis is the FITC value. In panels C and D
the region represented by M1 indicates the number of cells that are positive for FITC. This is
~ 1% in isotype control (C) and ~ 95 % after incubation with anti-CD56 (D). Panel E (I-IV)
shows uNK cells immunostained for CD56 (red) and ToPro (nuclear counterstain, blue),
Panel I purified uNK cells stained with mouse anti-human CD56, Panel II, is a high power
view of the same cells. Panel III, formalin-fixed section of 1st trimester decidua, (positive
control), Panel IV negative control. Scale bar = 20μm.
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Figure 2. Expression of receptors in uNK cells
Panel A. Expression of MR mRNA (203bp, upper panel) was detected in isolated uNK cells
from 1st trimester decidua and late-secretory phase endometrium, GAPDH (205bp,lower)
was detected in all samples. Panel B. Expression of LH/hCG receptor (203 bp, upper panel)
was not detected in isolated uNK cells from 1st trimester decidua or late-secretory phase
endometrium but as expected was present in a sample of CL, GAPDH (205bp lower) was
detectred in all samples. Lane M represents the DNA hyperladder. Lanes 1 to 4 show uNK
cells from 1st trimester decidua, lanes 5 to 7 shows uNK cells from non-pregnant late
secretory phase endometrium, lane 8 shows a first trimester decidual sample and lane 9 is a
sample of corpus luteum (positive control for LHR). Panels C to H: FACS analysis of uNK
cell surface antigen expression in all cases axis y is the PE [phycoerythrin] value and axis x
is the FITC [fluorescein isothiocyanate] value; C are unstained cells (D), isotype-matched
negative controls for FITC+PE, late-secretory endometrial MACS®–isolated uNK cell
sample negative controls FITC (E) and stained for CD56 (F) or MR (G). Panel H shows
analysis of cells co-stained for CD56 and MR, note cells positive for both markers in upper
right quadrant. One representative data set is shown of nine experiments performed.
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Figure 3. Localization of hCG and MR on uNK cells
Staining of purified uNK cells with antibodies directed against MR (green) and/or hCG
(red). Yellow staining shows areas of co localisation. Blue shows nuclear counterstain, To
Pro. The left hand column shows both MR and hCG staining superimposed, the middle
column-MR alone (green channel) and the right hand column hCG alone (red channel).
Panels I to III: cells were untreated. Panels IV to VI: cells were incubated with hCG alone
(10,000 ng/ml). Panels VII to IX: cells were incubated with hCG plus D-mannose (1mg/ml).
Panels X-XII: cells were incubated with deglycosylated hCG alone (10,000 ng/ml).
Kane et al. Page 12
Endocrinology. Author manuscript; available in PMC 2009 July 14.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 4. MTT proliferation analysis of uNK cell proliferation and mass spectrometry (MS)
analysis demonstrating effective deglycosylation of hCG
Panel A: Treatment with hCG alone induced proliferation of uNK cells in a dose-dependent
manner, with maximal proliferation observed with 10,000 ng/ml hCG treatment (p<0.001)
(green bars). Treatment of uNK cells with hCG plus D-mannose (1 mg/ml) did not induce
proliferation and this was also the case when cells were incubated with deglycosylated hCG
(10,000 ng/ml). a = p<0.001, 2-way ANOVA between groups. * = p<0.05, *** = p<0.001,
1-way ANOVA within group. n = 5 secretory phase endometrial uNK cell samples. Graph B
shows MS analysis of glycosylated hCG, intact protein is ~36 kDa (arrow), α subunit is 13
kDa. Graph C shows MS analysis of deglycosylated hCG with the size of protein reduced to
~22 kDa (*), α subunit is 11.5 kDa. Graph D depicts the MS analysis of the deglycosylation
enzyme, PNGase alone.
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